The 5′-Isobutyryl Ester Prodrug of 4′-Thiouridine Inhibits SARS-CoV-2 Replication in Culture and in a Syrian Hamster Infection Model
Authors:
Open Access
- 10 July 2026
- journal article
- Published by American Chemical Society (ACS) in ACS Omega
- Vol. 11 (29) , 43231-43241
Abstract
Although the SARS-CoV-2 pandemic is now largely controlled through widespread vaccination and available therapeutics, emerging variants could undermine their overall effectiveness. 4′-Thiouridine (TU) and its 5′-isobutyryl prodrug (iBu TU) were identified as potent inhibitors of SARS-CoV-2 replication across various cell models, including advanced primary human respiratory models. Both compounds exhibited no significant toxicity across a range of cell culture systems, with no signs of mitochondrial damage or elevated lactic acid production. Furthermore, TU and iBu TU tested negative for mutagenicity, aneugenic and clastogenic effects, alleviating concerns about genotoxicity. They also showed no interaction with a broad spectrum of ion channels, GPCRs, and enzymes, further confirming their favorable safety profile. TU is metabolized intracellularly to its active triphosphate form (TU-TP), which effectively disrupts viral RNA replication by acting as a delayed chain terminator. iBu TU is rapidly converted to TU in plasma and displays superior oral bioavailability compared to TU (F = 90% vs 42% in monkeys). In a Syrian hamster model infected with SARS-CoV-2, oral iBu TU significantly reduced viral loads (1.7 to 4.5 log10) and improved lung health without adverse effects. These findings highlight iBu TU as a promising oral antiviral candidate for treating SARS-CoV-2 infection.Keywords
Funding Information
- National Institute of Allergy and Infectious Diseases (1R01AI110577)
- Pfizer
This publication has 27 references indexed in Scilit:
- Binding of human ACE2 and RBD of Omicron enhanced by unique interaction patterns among SARS‐CoV‐2 variants of concernJournal of Computational Chemistry, 2022
- A new imaging platform (iScreen) allows for the concurrent assessment of micronucleus induction and genotoxic mode of action in human A375 cellsEnvironmental and Molecular Mutagenesis, 2022
- Structural and functional characterizations of infectivity and immune evasion of SARS-CoV-2 OmicronCell, 2022
- Comparison of anti-SARS-CoV-2 activity and intracellular metabolism of remdesivir and its parent nucleosideCurrent Research in Pharmacology and Drug Discovery, 2021
- Remdesivir Is Effective in Combating COVID-19 because It Is a Better Substrate than ATP for the Viral RNA-Dependent RNA PolymeraseiScience, 2020
- Predicting Clearance Mechanism in Drug Discovery: Extended Clearance Classification System (ECCS)Pharmaceutical Research, 2015
- Development of a new permeability assay using low‐efflux MDCKII cellsJournal of Pharmaceutical Sciences, 2011
- Global Kinetic Explorer: A new computer program for dynamic simulation and fitting of kinetic dataAnalytical Biochemistry, 2009
- Antiviral hepatitis and antiretroviral drug interactionsJournal of Hepatology, 2005
- Physiological concentrations of purines and pyrimidinesMolecular and Cellular Biochemistry, 1994